OFFICE NO 5 & 6, 3RD FLOOR,
EARTH ALPHA COMPLEX
VASNA BHAYLI RD, VADODARA
GUJARAT, INDIA
What Are Generic Medicines?
Generic medicines are developed to provide an alternative to a reference medicine. Buyers should verify the active ingredient, strength, dosage form and other product characteristics rather than relying on a similar product name.
The evidence required to establish equivalence depends on the medicine and the applicable regulatory pathway. WHO guidance describes requirements for demonstrating the interchangeability of multisource, or generic, pharmaceutical products without compromising quality, safety and efficacy.
Generic medicines may be supplied under their nonproprietary names or marketed using brand names. Packaging, appearance and certain inactive ingredients can differ, subject to the relevant regulatory requirements.
Why Evaluate Generic Medicine Export Requirements?
An attractive quotation does not establish whether a medicine can be legally imported, distributed or supplied in the buyer’s country.
International procurement requires coordination between the exporter, manufacturer, importer and relevant regulatory professionals. Product registration, technical documentation, labelling and shipping requirements should be assessed before commercial commitments are made.
Early evaluation helps buyers avoid ordering products with unsuitable specifications, incomplete documentation or packaging that does not meet local requirements.
What International Buyers Should Check
Before sourcing generic medicines from India, buyers should carefully evaluate several important factors.
1. Manufacturer and Exporter Identity
Identify the actual manufacturer of each medicine. An exporter may source products from another company rather than operate its own manufacturing facility.
Confirm the manufacturer’s legal name, facility address and relevant manufacturing authorisations. Check that the documentation covers the proposed products and dosage forms.
Where an intermediary is involved, establish its relationship with the manufacturer and its ability to obtain authentic technical and batch documents. Names, addresses and product details should be consistent across the quotation, supporting documents and proposed supply agreement.
2. Exact Product Specifications
Agree on the precise medicine being purchased before discussing final pricing or shipment.
Product specifications should identify the active ingredient, strength, dosage form, route of administration, pack size, shelf life and storage conditions. Where relevant, confirm whether the product is immediate-release, modified-release or another specialised formulation.
Products containing the same active ingredient may still differ in important ways. Buyers should also establish the applicable quality specifications and any destination-market requirements for formulation or presentation.
A clear product specification reduces the risk of receiving a medicine that differs from the registered or intended product.
3. Destination-Market Registration and Import Requirements
Determine the regulatory pathway that applies in the destination country.
Depending on the product and market, requirements may include marketing authorisation, importer licensing, manufacturing-site assessment, import permission and approved labelling.
Confirm who will hold the product registration, who will submit the application and who will provide the necessary technical information. These responsibilities should be agreed before procurement begins.
The exporter should also establish the applicable Indian permissions. CDSCO publishes guidance for export NOC applications, including documentation concerning importing-country approval status in the pathways covered by that guidance. Buyers should avoid assuming that one export procedure applies to every medicine.
4. Manufacturing Standards and GMP Evidence
Review the evidence supporting the manufacturer’s Good Manufacturing Practices, or GMP, claims.
GMP concerns the controls used to consistently manufacture products to appropriate quality standards. It addresses production risks such as contamination, product mix-ups and incorrect labelling.
Check the issuing authority, manufacturing-site address, scope and current status of the relevant documents. Evidence for one facility or dosage form should not be assumed to cover every product offered by the supplier.
Claims such as “WHO-GMP” should be interpreted carefully. Ask who issued the documentation and what it covers. If WHO prequalification is claimed, verify the specific product and manufacturing sites involved.
5. Bioequivalence and Supporting Technical Evidence
For generic medicines, buyers should establish what evidence their medicines authority requires to demonstrate equivalence to an acceptable reference product.
Depending on the medicine and regulatory pathway, this may involve bioequivalence studies, comparative dissolution testing or an accepted biowaiver.
Do not assume that every generic medicine requires the same type of study. Equally, the presence of the same active ingredient does not by itself establish regulatory interchangeability.
WHO’s generic medicine assessment considers product quality, manufacturing sites and relevant evidence of equivalence. Buyers should have qualified regulatory professionals assess whether the available evidence is suitable for their application.
6. Batch Testing and Certificates of Analysis
A Certificate of Analysis, commonly called a CoA, provides testing information for a particular batch.
Check that the product name, strength and batch number match the medicines being supplied. Review the specifications, reported results, relevant dates and document authorisation.
A sample CoA may support an initial supplier assessment, but buyers should obtain the agreed documentation for the actual shipment.
A CoA should be considered alongside manufacturing controls, regulatory status and supply-chain records. It does not independently establish that the medicine is authorised for sale in the destination market.
7. Pharmaceutical and Shipping Documentation
Agree on a documentation checklist before placing the order.
Depending on the transaction, documents may include manufacturing authorisations, GMP evidence, product registration documents, batch CoAs, commercial invoices, packing lists and transport documents.
A Certificate of a Pharmaceutical Product, or CPP, may also be requested by the destination authority. The CPP is the principal document under the WHO Certification Scheme for pharmaceutical products moving in international commerce. Its relevance and acceptance should be confirmed for the intended market.
Check document authenticity, consistency and any requirements for translation, legalisation or electronic verification.
8. Packaging and Labelling
Packaging and labelling should match the approved requirements of the destination market.
Confirm the required language, product name, strength, batch details, expiry information, storage instructions and manufacturer details. Patient information leaflets, local registration details and traceability features may also be required.
Agree on packaging artwork approval and version control before production. Buyers should ensure that changes to labels or pack sizes receive the necessary review.
Suitable packaging should protect the medicine against relevant risks such as moisture, light and physical damage.
9. Storage, Transport and Remaining Shelf Life
Product quality must be maintained throughout storage and shipment.
Agree on transport conditions that match the medicine’s labelled storage requirements. For temperature-sensitive products, establish suitable packaging, monitoring and procedures for assessing temperature excursions.
Set minimum remaining shelf-life requirements at an agreed point, such as dispatch or delivery. Consider shipping time, customs clearance, local distribution and expected demand.
Responsibilities for damaged goods, delayed shipments and products exposed to unsuitable conditions should be recorded in the supply agreement.
10. Commercial Terms and Intellectual Property
Assess the full procurement cost rather than comparing unit prices alone.
Clarify minimum order quantities, production lead times, payment terms, freight responsibilities, insurance and responsibility for customs-related costs.
Buyers should also assess applicable patent, trademark and other intellectual-property restrictions before importing or marketing a generic medicine. A product’s availability from an exporter does not establish that its sale is permitted in every destination country.
Clear commercial terms help prevent disputes and support realistic supply planning.
Evaluating Supplier Quality and Supply Capability
A reliable supplier should be able to explain how it manages product complaints, quality investigations, significant changes and recalls.
Ask how the supplier will notify buyers about changes to manufacturing sites, formulations, packaging or regulatory status. Confirm who will investigate a quality complaint and how affected batches will be traced.
Depending on the medicine and identified risks, a technical assessment or supplier audit may be appropriate.
A written quality agreement can clarify responsibilities for specifications, batch documentation, product release, transport, change notification and complaint handling.
Why Ongoing Supplier Monitoring Matters
Supplier evaluation should continue after the first shipment.
Monitor documentation accuracy, packaging condition, remaining shelf life, delivery performance and the handling of quality issues. Review relevant authorisations and reassess the supplier when significant changes occur.
Maintain records linking each shipment to its manufacturer, batch numbers and supporting documents. These records help investigate problems and coordinate corrective action when necessary.
Consistent monitoring provides a stronger basis for repeat purchasing than relying only on an initial quotation or certification claim.
Why the Right Generic Medicine Export Partner Matters
Choosing a generic medicine export partner involves balancing verified quality, regulatory suitability, transparent communication and dependable supply.
A responsible exporter should identify the actual manufacturer, explain product availability accurately and provide the agreed documents without making unsupported approval claims.
For international buyers sourcing generic medicines from India, careful product evaluation and clearly assigned responsibilities support informed procurement and a more reliable long-term supply relationship.
Share This News